Patent Term Compensation in México

The new Federal Law for Protection of the Industrial Property provides a “supplementary certificate” if, during the prosecution of a patent with the Mexican Institute of Industrial Property (IMPI), there are unreasonable delays for a period of more than five years between the filing date of the application in Mexico and the granting of the patent. The rule for compensation is one day of compensation for every two days of delay up to a maximum of 5 years of compensation. However, this compensation mechanism only is applicable to patents filed and prosecuted with IMPI after November 5, 2020.

In October 2020, the Mexican Supreme Court issued a relevant judgment related to patent term adjustment applicable to patents filed and prosecuted before November 5, 2020. This ruling concluded that the term of protection should be compensated if there is evidence of an unjustified delay during the patent prosecution, in accordance with Article 1709, section 12 of the North American Free Trade Agreement, which establishes that the term of patents cannot be less than 20 years counted from their filing date, or rather, 17 years from the granting date. In compliance with the principle of “greatest benefit,” in the constitutional venue where the case was studied, the Supreme Court considered as a remedy that the compensation should be 17 years from granting date. This precedent was not unanimous; it is not binding but highly persuasive.

At present, there is a controversy on the remedy of the 17 years from granting date as compensation and the rationale behind the terms to consider a delay during patent prosecution established in said decision.

The ambiguity of the decision has resulted in frivolous compensation petitions even when there are no delays during patent prosecution.

OLIVARES considers that patent compensation should be applicable to patents prosecuted and granted before or after the entry into force of the new IP Law, provided there is an unreasonable delay during patent prosecution. However, in both cases, the remedy of the compensation cannot be excessive since the new law already establishes the parameter for the patent prosecution delay and the rules to adjust or compensate the patent term, which may be applied by analogy to those patents prosecuted before November 5, 2020, and not the other way around, since the remedy and the lack of delay parameters established in the Supreme Court’s decision could exceed the current legal parameters in violation of the statutory law and would contradict the entire patent system and its current term adjustment.

We expect that said criteria and considerations will be defined shortly due to pending litigations with the Courts.

FOR FURTHER INFORMATION ON THE CONTENT OF THIS NEWSLETTER, PLEASE CONTACT:

Armando Arenas

Partner

Armando Arenas joined OLIVARES in 2000 and became a partner in January 2017. He has experience working on a range of IP matters, including consulting and litigation on trademark, patent, unfair competition, trade dress protection, and misleading advertising cases before the Mexican Institute of Industrial Property (IMPI), Federal Court of Tax and Administrative Affairs (FCTA), Federal Circuit Courts (FCC) and the Supreme Court of Justice (SCJ) Regulatory Affairs and Public Acquisitions.

Alejandro Luna F.

Partner

Alejandro Luna joined OLIVARES in 1996 and being made partner in 2005, he has been instrumental to the firm’s IP Litigation, Regulatory, and Administrative Litigation practices. He co-chairs the Life Sciences & Pharmaceutical Law industry group and coordinates the Litigation Department.

Daniel Sánchez

Partner

Daniel Sanchez joined OLIVARES in 2000 and became a partner in 2011. He is one of the leading intellectual property (IP) and administrative litigators in Mexico and is recognized by industry rankings and publications.

Armando Arenas

Partner

Armando Arenas joined OLIVARES in 2000 and became a partner in January 2017. He has experience working on a range of IP matters, including consulting and litigation on trademark, patent, unfair competition, trade dress protection, and misleading advertising cases before the Mexican Institute of Industrial Property (IMPI), Federal Court of Tax and Administrative Affairs (FCTA), Federal Circuit Courts (FCC) and the Supreme Court of Justice (SCJ) Regulatory Affairs and Public Acquisitions.

Rommy Morales

Partner

Rommy Morales is partner of OLIVARES, joining the company in 2008. She has counselled a number of the world’s top pharmaceutical, biotechnology, and chemical companies regarding the protection and enforcement of their intellectual property rights. She co-chairs the Patent Group, overseeing the filing and prosecution of patents. Because of her extensive technical expertise and background, Rommy Morales is one of the foremost experts on the prosecution and enforcement of pharmaceutical patents in Mexico.

WHO CAN BE FOUND AT THE FOLLOWING NUMBER:

+52(55) 5322 3000

Newsletters

Return...